CIK 0001339005 · <br>Emerging growth company
FEMASYS INC
Sign in to watch- Ticker
- FEMY
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113713499
- Phone
- 770-500-3910
- Business address
- 3950 JOHNS CREEK COURT, SUITE 100, SUWANEE, GA, 30024
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-30 | Moorhead John Hunnewell Jr Director | Grant or award · Stock Option (Right to Buy) | +1,760 | 1,760 | ||
| 2026-08-07 | Mifek Jeffrey Gerald Chief Clinical-Medical Affairs | Purchase | +3,125 | $3.20 | $10K | 3,125 |
| 2026-08-07 | Mifek Jeffrey Gerald Chief Clinical-Medical Affairs | Grant or award · Common Stock Purchase Warrant | +3,125 | 3,125 | ||
| 2026-08-07 | Mifek Jeffrey Gerald Chief Clinical-Medical Affairs | Grant or award · Common Stock Purchase Warrant (Milestone) | +3,125 | 3,125 | ||
| 2026-08-07 | Sipos Jeremy Alexander Chief Technology Officer | Purchase | +3,125 | $3.20 | $10K | 3,125 |
| 2026-08-07 | Sipos Jeremy Alexander Chief Technology Officer | Grant or award · Common Stock Purchase Warrant | +3,125 | 3,125 | ||
| 2026-08-07 | Sipos Jeremy Alexander Chief Technology Officer | Grant or award · Common Stock Purchase Warrant (Milestone) | +3,125 | 3,125 | ||
| 2026-08-07 | Canning John Charles Chief Operating Officer | Purchase | +4,375 | $3.20 | $14K | 4,375 |
| 2026-08-07 | Canning John Charles Chief Operating Officer | Grant or award · Common Stock Purchase Warrant | +4,375 | 4,375 | ||
| 2026-08-07 | Canning John Charles Chief Operating Officer | Grant or award · Common Stock Purchase Warrant (Milestone) | +4,375 | 4,375 | ||
| 2026-08-07 | Elefant Dov Chief Financial Officer | Purchase | +15,625 | $3.20 | $50K | 15,625 |
| 2026-08-07 | Elefant Dov Chief Financial Officer | Grant or award · Common Stock Purchase Warrant | +15,625 | 15,625 | ||
| 2026-08-07 | Elefant Dov Chief Financial Officer | Grant or award · Common Stock Purchase Warrant (Milestone) | +15,625 | 15,625 | ||
| 2026-08-07 | Lee-Sepsick Kathy Chief Executive Officer | Purchase | +15,625 | $3.20 | $50K | 15,625 |
| 2026-08-07 | Lee-Sepsick Kathy Chief Executive Officer | Grant or award · Common Stock Purchase Warrant | +15,625 | 15,625 | ||
| 2026-08-07 | Lee-Sepsick Kathy Chief Executive Officer | Grant or award · Common Stock Purchase Warrant (Milestone) | +15,625 | 15,625 | ||
| 2026-07-06 | Mifek Jeffrey Gerald Chief Clinical-Medical Affairs | Grant or award · Stock Option (Right to Buy) | +6,250 | 6,250 | ||
| 2026-06-24 | Eichenbaum Kenneth D. Director | Grant or award · Stock Option (Right to Buy) | +880 | 880 | ||
| 2026-06-24 | Uzialko Edward R Director | Grant or award · Stock Option (Right to Buy) | +880 | 880 | ||
| 2026-06-24 | Milnes Alistair Director | Grant or award · Stock Option (Right to Buy) | +880 | 880 |
Page 1 of 7 · 127 trades